House Subcommittee Holds Hearing on HIPAA Privacy Rule

March 20, 2001 -- House Energy and Commerce Health Subcommittee Chairman Michael Bilirakis (R-FL) today released the witness list for a hearing entitled, "Assessing HIPAA: How Federal Medical Record Privacy Regulations Can Be Improved."

The hearing, to take place this Thursday, March 22, 2001, at 10:00 a.m. in room 2123 of the Rayburn House Office Building, will focus on the unintended consequences of the Health Insurance Portability and Accountability Act’s (HIPAA) medical record privacy regulations.

The following witnesses are scheduled to appear at Thursday’s hearing:

Dr. John Melski, Medical Director of Informatics, Marshfield Clinic - Marshfield, WI

John D. Clough, MD, Director of Health Affairs, Cleveland Clinic Foundation - Cleveland, OH

Mr. Bob Heird, Senior Vice President, Anthem BlueCross BlueShield - Indianapolis, IN

Mr. Carlos R. Ortiz, Director of Government Affairs, CVS Pharmacy - Woonsocket, RI

Ms. Janlori Goldman, Director, Health Privacy Project, Institute for Health Care Research and Policy, Georgetown University - Washington, DC

Dr. Paul Appelbaum, A.F. Zeleznik Professor of Psychiatry, Chairman, Department of Psychiatry, University of Massachusetts Medical School - Worcester, MA